Sarah Hein is the founder of March Biosciences. March Biosciences has raised $52M in total funding. Latest round: Series A. Based in Houston, United States.
Sarah Hein is the Co-founder & CEO of March Biosciences, a Houston-based clinical-stage cell therapy company targeting challenging hematological malignancies. She previously served as an Entrepreneur in Residence at TMC Innovation and is a serial biotech entrepreneur.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide